PDUFA dates are listed on an FDA tracker site. Pretty easy to find. You don’t get a lot of bang for your buck on approvals anymore as they usually are followed by an offering and small bios are terrible at self commercialization. P3 data read outs and BLA / NDA acceptances are better. That comes from calls / SEC filings, and following people more in the know than me. MYOV was an easy call as it was already 52% owned by Sumi and PFE was doing their commercialization.